Neuropsychiatric Effects of HIV and Toxoplasma Gondii Encephalitis: A Case Study

Introduction HIV infection can lead to neurological and psychiatric disorders by affecting the central nervous system. Toxoplasma gondii can cause encephalitis in immunocompromised individuals, particularly damaging brain regions such as the frontal cortex and basal ganglia. These neuroanatomical disruptions can influence dopaminergic and serotonergic neurotransmitter pathways, resulting in severe neuropsychiatric symptoms like behavioral disinhibition, personality changes, and psychotic manifestations (Vidal JE. J Int Assoc Provid AIDS Care 2019; 18:2325958219867315). Objectives This case seeks to demonstrate the neuropsychiatric effects of HIV and Toxoplasma gondii infections on neuronal function and behavior, emphasizing the importance of continuous assessment and integrated treatment approaches. Methods A 49-year-old male patient, with no known medical history, developed Toxoplasma gondii encephalitis after being diagnosed with HIV. Following discharge from the infectious disease ward, the patient exhibited increased irritability, impulsivity, hypersexuality, visual hallucinations, disorganized speech, and risky behaviors, along with cognitive dysfunction and social norm violations. The patient’s symptoms partially improved with a treatment regimen of 15 mg olanzapine and 1000 mg valproic acid. However, the patient’s ongoing course, parkinsonism symptoms emerged, prompting the discontinuation of valproic acid and the consideration of quetiapine. The patient’s follow-up treatment is ongoing. Results HIV and Toxoplasma gondii disrupt neuronal function through inflammatory responses and microglial activation in the central nervous system. HIV does not directly damage neurons, but inflammation from cytokines released by microglia can lead to neurodegenerative conditions. Dopaminergic dysfunction is linked to psychotic symptoms, while serotonergic disruptions contribute to depression and anxiety. Frontal lobe and basal ganglia damage impair executive functions (planning, decision-making, impulse control), causing increased impulsivity, risky behaviors, emotional dysregulation, irritability, lack of empathy, behavioral disinhibition, hypersexuality, and cognitive dysfunction. These changes are tied to structural damage in the frontal cortex, necessitating long-term follow-up and comprehensive treatment. Diagnostic imaging often shows white matter lesions, basal ganglia damage, and frontal cortex atrophy. Treatment involves antiretroviral therapy, low-dose antipsychotics, mood stabilizers for managing symptoms (Bartolomé Del Pino LE et al . Actas Esp Psiquiatr 2024; 52(2):149-60). Conclusions HIV and Toxoplasma gondii infections induce significant central nervous system impairment, leading to neuropsychiatric disorders. This case illustrates their impact on neurotransmitter systems, manifesting as psychosis, cognitive dysfunction, and behavioral disturbances. Continued monitoring and comprehensive treatment are essential. Disclosure of Interest None Declared

Authors

Institutions

Publication Details

Journal
European Psychiatry
Published
2025-04-01
DOI
https://doi.org/10.1192/j.eurpsy.2025.1689
Primary Topic
Toxoplasma gondii Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuropsychiatric Effects of HIV and Toxoplasma Gondii Encephalitis: A Case Study

T. Incekurk Kizilca, B. Yildirim Cinek
European Psychiatry
Toxoplasma gondii Research Studies
article

Neuropsychiatric Effects of HIV and Toxoplasma Gondii Encephalitis: A Case Study

T. Incekurk Kizilca, B. Yildirim Cinek
article en

Abstract

Introduction HIV infection can lead to neurological and psychiatric disorders by affecting the central nervous system. Toxoplasma gondii can cause encephalitis in immunocompromised individuals, particularly damaging brain regions such as the frontal cortex and basal ganglia. These neuroanatomical disruptions can influence dopaminergic and serotonergic neurotransmitter pathways, resulting in severe neuropsychiatric symptoms like behavioral disinhibition, personality changes, and psychotic manifestations (Vidal JE. J Int Assoc Provid AIDS Care 2019; 18:2325958219867315). Objectives This case seeks to demonstrate the neuropsychiatric effects of HIV and Toxoplasma gondii infections on neuronal function and behavior, emphasizing the importance of continuous assessment and integrated treatment approaches. Methods A 49-year-old male patient, with no known medical history, developed Toxoplasma gondii encephalitis after being diagnosed with HIV. Following discharge from the infectious disease ward, the patient exhibited increased irritability, impulsivity, hypersexuality, visual hallucinations, disorganized speech, and risky behaviors, along with cognitive dysfunction and social norm violations. The patient’s symptoms partially improved with a treatment regimen of 15 mg olanzapine and 1000 mg valproic acid. However, the patient’s ongoing course, parkinsonism symptoms emerged, prompting the discontinuation of valproic acid and the consideration of quetiapine. The patient’s follow-up treatment is ongoing. Results HIV and Toxoplasma gondii disrupt neuronal function through inflammatory responses and microglial activation in the central nervous system. HIV does not directly damage neurons, but inflammation from cytokines released by microglia can lead to neurodegenerative conditions. Dopaminergic dysfunction is linked to psychotic symptoms, while serotonergic disruptions contribute to depression and anxiety. Frontal lobe and basal ganglia damage impair executive functions (planning, decision-making, impulse control), causing increased impulsivity, risky behaviors, emotional dysregulation, irritability, lack of empathy, behavioral disinhibition, hypersexuality, and cognitive dysfunction. These changes are tied to structural damage in the frontal cortex, necessitating long-term follow-up and comprehensive treatment. Diagnostic imaging often shows white matter lesions, basal ganglia damage, and frontal cortex atrophy. Treatment involves antiretroviral therapy, low-dose antipsychotics, mood stabilizers for managing symptoms (Bartolomé Del Pino LE et al . Actas Esp Psiquiatr 2024; 52(2):149-60). Conclusions HIV and Toxoplasma gondii infections induce significant central nervous system impairment, leading to neuropsychiatric disorders. This case illustrates their impact on neurotransmitter systems, manifesting as psychosis, cognitive dysfunction, and behavioral disturbances. Continued monitoring and comprehensive treatment are essential. Disclosure of Interest None Declared

European PsychiatryVol. 68(S1)
University of Health Science (KH)
Openalex Percentile: Top 74%
Toxoplasma gondii Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.